Neoteryx has been acquired by Trajan Group Holdings

Neoteryx, LLC has been sold to Trajan Group Holdings Limited.

Neoteryx, based in Southern California, is a global leader in blood micro-sampling, with operations in the USA and Europe. Its customers include scientific researchers, laboratories and health providers working to advance telemedicine, pharmaceutical development, biotechnology research and clinical diagnostics.

Trajan Group Holdings is a global developer and manufacturer of analytical and life sciences products and devices used in the analysis of biological, food, water and other environmental samples. The company has more than 520 employees, operating across the USA, Australia, Europe and Malaysia.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Neoteryx, LLC in this transaction.

Services

M&A sell-side

Parteien

„At Neoteryx we developed innovative technology to transform specimen collection, and our goal was to achieve global commercial scale through a strategic transaction. The Oaklins team brought deep industry expertise and relationships to this assignment and a sharp focus on achieving our objectives. Our partnership with Trajan is an exciting outcome for the Neoteryx team and our customers as we together leverage micro-sampling to create advanced healthcare solutions.“

Fasha Mahjoor

Founder and CEO, Neoteryx, LLC

Sprechen Sie mit dem Deal-Team

Michael S. Goldman

Geschäftsführer

New York, Vereinigte Staaten
Oaklins TM Capital

Profil ansehen Kontaktaufnahme

James McLaren

Geschäftsführer

New York, Vereinigte Staaten
Oaklins TM Capital

Profil ansehen Kontaktaufnahme

John Dean

Associate Director

Atlanta, Vereinigte Staaten
Oaklins TM Capital

Profil ansehen Kontaktaufnahme

Relevante Transaktionen

Leika Medical Equipments Ltd. has been acquired by Angus Capital

Private Equity | Gesundheitswesen

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Weitere Informationen

Phen’X Technologies has sold a majority stake to Ciclad

Private Equity | Gesundheitswesen | Maschinen- & Anlagenbau, Komponenten

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Weitere Informationen

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Gesundheitswesen | Technologie, Medien und Telekommunikation

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Weitere Informationen